Powered by Max Banner Ads 

Although you do have a gorgeous california king duvet covers, it doesn't ensure you're going to get the best night sleep.

Your family physician may be a valuable resource in understanding the fundamental causes of insomnia. A diagnosis of insomnia typically defines the condition as being chronic or temporary. The type of insomnia that warrants serious concern is the chronic variety. There may be several factors at play that are causing your insomnia, and you should consider talking with your doctor to help sort them out. You may have some underlying medical condition, and if so then that needs to be determined. But often you can find solid clues by examining your lifestyle. If you are experiencing a high level of stress on the job, then that very well could play a part. This article will discuss three approaches or insomnia cures that may work for you.

Your sleep environment is known to play a sizable role in how well you sleep through the night. For most people their sleep setting is their bedroom. Blocking the light from entering your bedroom will help you enjoy a more restful slumber. Sleeping during the day is nearly always a challenge for people whose jobs require that they work at night. A moderately cooler room is better for more restful sleep than one that is too warm. You may think that the cool sheets will be uncomfortable, but you'll quickly find that they warm to your body.

Nearly all the components of the contemporary diet contain some manner of stimulant. Some hot chocolate before bed might be part of your evening ritual to help you relax. But also realize that your cup of hot cocoa contains sugar which is known to be a strong stimulant. Caffeinated carbonated beverages such as Pepsi or Coca Cola are known to retard sleep and should not be consumed in the evening. If you are not accustomed to drinking caffeine, then you should never consume it less than eight hours before your bedtime. Nicotine and even alcohol in moderation will interfere with the quality of your sleep.

If you are someone who has an inability to calm yourself down for sleep, that is something you should work on. Very many people in industrialized nations are not as relaxed as they should be. Plus, there are many external sources of stress in daily life, and that is especially true in the US. If you have financial worries, then that certainly can be a major contributor to stress levels. One very good outlet for stress is exercising. If you have difficulty finding time to work out, then even something like taking a walk in the evening will help. When something is interfering with your sleep, then you must take some kind of action to minimize or eliminate the problem.

It's worth stepping back and taking a solid inventory of the ways that your daily routine may be contributing factors. You may find that some of the causes become easily discernible just by thinking about them. You can then go after the best approach for treating your insomnia.


Anticonvulsant studied for primary insomnia.(Clinical Rounds): An article from: Family Practice News
Overall Rating:
Total Customer Reviews: (0)
List Price: $5.95
Sale Price: $5.95
Availability: Available for download now
This digital document is an article from Family Practice News, published by International Medical News Group on February 1, 2005. The length of the article is 732 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Anticonvulsant studied for primary insomnia.(Clinical Rounds)
Author: Patrice Wendling
Publication: Family Practice News (Magazine/Journal)
Date: February 1, 2005
Publisher: International Medical News Group
Volume: 35 Issue: 3 Page: 88(1)

Distributed by Thomson Gale

Abundance of insomnia drugs in the pipeline.(Clinical Rounds): An article from: Family Practice News
Overall Rating:
Total Customer Reviews: (0)
List Price: $5.95
Sale Price: $5.95
Availability: Available for download now
This digital document is an article from Family Practice News, published by International Medical News Group on November 1, 2005. The length of the article is 1046 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Abundance of insomnia drugs in the pipeline.(Clinical Rounds)
Author: Bruce Jancin
Publication: Family Practice News (Magazine/Journal)
Date: November 1, 2005
Publisher: International Medical News Group
Volume: 35 Issue: 21 Page: 75(1)

Distributed by Thomson Gale

FDA approves eszopiclone to treat insomnia.(News): An article from: Family Practice News
Overall Rating:
Total Customer Reviews: (0)
List Price: $5.95
Sale Price: $5.95
Availability: Available for download now
This digital document is an article from Family Practice News, published by International Medical News Group on February 1, 2005. The length of the article is 379 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: FDA approves eszopiclone to treat insomnia.(News)
Author: Alicia Ault
Publication: Family Practice News (Magazine/Journal)
Date: February 1, 2005
Publisher: International Medical News Group
Volume: 35 Issue: 3 Page: 14(1)

Distributed by Thompson Gale

Short half-life sets investigational drug for insomnia apart.(Clinical Rounds): An article from: Family Practice News
Overall Rating:
Total Customer Reviews: (0)
List Price: $5.95
Sale Price: $5.95
Availability: Available for download now
This digital document is an article from Family Practice News, published by International Medical News Group on September 15, 2004. The length of the article is 773 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Short half-life sets investigational drug for insomnia apart.(Clinical Rounds)
Author: Mitchel L. Zoler
Publication: Family Practice News (Magazine/Journal)
Date: September 15, 2004
Publisher: International Medical News Group
Volume: 34 Issue: 18 Page: 50(1)

Distributed by Thomson Gale

Consider Duration, Onset of Action When Choosing an Insomnia Agent.(benzodiazepine receptors)(Brief Article): An article from: Family Practice News
Overall Rating:
Total Customer Reviews: (0)
List Price: $5.95
Sale Price: $5.95
Availability: Available for download now
This digital document is an article from Family Practice News, published by International Medical News Group on April 1, 2000. The length of the article is 1499 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.Citation DetailsTitle: Consider Duration, Onset of Action When Choosing an Insomnia Agent.(benzodiazepine receptors)(Brief Article)Author: Doug BrunkPublication: Family Practice News (Magazine/Journal)Date: April 1, 2000Publisher: International Medical News GroupVolume: 30 Issue: 7 Page: 28Article Type:... [Read More]

Eszopiclone consistently effective for insomnia.(Clinical Rounds): An article from: Family Practice News
Overall Rating:
Total Customer Reviews: (0)
List Price: $5.95
Sale Price: $5.95
Availability: Available for download now
This digital document is an article from Family Practice News, published by International Medical News Group on August 1, 2004. The length of the article is 862 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Eszopiclone consistently effective for insomnia.(Clinical Rounds)
Author: Patrice G.W. Norton
Publication: Family Practice News (Magazine/Journal)
Date: August 1, 2004
Publisher: International Medical News Group
Volume: 34 Issue: 15 Page: 52(1)

Distributed by Thomson Gale

Novel drug cuts insomnia; no drowsiness or rebound.(Mental Health)(eplivanserin): An article from: Family Practice News
Overall Rating:
Total Customer Reviews: (0)
List Price: $9.95
Sale Price: $9.95
Availability: Available for download now
This digital document is an article from Family Practice News, published by International Medical News Group on November 15, 2008. The length of the article is 367 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser.

Citation Details
Title: Novel drug cuts insomnia; no drowsiness or rebound.(Mental Health)(eplivanserin)
Author: Bruce Jancin
Publication: Family Practice News (Magazine/Journal)
Date: November 15, 2008
Publisher: International Medical News Group
Volume: 38 Issue: 22 Page: 19(1)

Distributed by Gale, a part of Cengage Learning

Long-Term Zaleplon Appears Safe, Effective for Sleep Disorder.: An article from: Family Practice News
Overall Rating:
Total Customer Reviews: (0)
List Price: $5.95
Sale Price: $5.95
Availability: Available for download now
This digital document is an article from Family Practice News, published by International Medical News Group on November 15, 1999. The length of the article is 361 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.Citation DetailsTitle: Long-Term Zaleplon Appears Safe, Effective for Sleep Disorder.Author: Carl ShermanPublication: Family Practice News (Magazine/Journal)Date: November 15, 1999Publisher: International Medical News GroupVolume: 29 Issue: 22 Page: 45Article Type: Product/Service EvaluationDistributed by Thomson... [Read More]

  

Switch to our mobile site